Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Publication Detail

Title: GADD45β mediates p53 protein degradation via Src/PP2A/MDM2 pathway upon arsenite treatment.

Authors: Yu, Y; Huang, H; Li, J; Zhang, J; Gao, J; Lu, B; Huang, C

Published In Cell Death Dis, (2013 May 16)

Abstract: Growth arrest and DNA-damage-inducible, beta (GADD45β) has been reported to inhibit apoptosis via attenuating c-Jun N-terminal kinase (JNK) activation. We demonstrated here that GADD45β mediated its anti-apoptotic effect via promoting p53 protein degradation following arsenite treatment. We found that p53 protein expression was upregulated in GADD45β-/- cells upon arsenite exposure as compared with those in GADD45β+/+ cells. Further studies showed that GADD45β attenuated p53 protein expression through Src/protein phosphatase 2A/murine double minute 2-dependent p53 protein-degradation pathway. Moreover, we identified that GADD45β-mediated p53 protein degradation was crucial for its anti-apoptotic effect due to arsenite exposure, whereas increased JNK activation was not involved in the increased cell apoptotic response in GADD45β-/- cells under same experimental conditions. Collectively, our results demonstrate a novel molecular mechanism responsible for GADD45β protection of arsenite-exposed cells from cell death, which provides insight into our understanding of GADD45β function and a unique compound arsenite as both a cancer therapeutic reagent and an environmental carcinogen. Those novel findings may also enable us to design more effective strategies for utilization of arsenite for the treatment of cancers.

PubMed ID: 23681232 Exiting the NIEHS site

MeSH Terms: Animals; Antigens, Differentiation/genetics; Antigens, Differentiation/metabolism*; Apoptosis/drug effects*; Arsenites/toxicity*; HCT116 Cells; Humans; JNK Mitogen-Activated Protein Kinases/metabolism; Mice; Phosphorylation/drug effects; Protein Phosphatase 2/metabolism*; Proto-Oncogene Proteins c-mdm2/metabolism*; Tumor Suppressor Protein p53/metabolism*; src-Family Kinases/metabolism*

to Top